<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 101 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page100.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=101">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 101 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 101</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=101"><img src="../thumb/101.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>70 / 2020-04                                                        Musculo-Skeletal Agents - 4.1.1
   skin reacts.incl.Stev.-Johns.& Lyell syndr., alopec., photosens. react.,   Contraindications: Pept.ulc., GI perforat./ulcer./ bleed. hist.relat.  GI disturbs. incl.bleed, ulcerat.colit exacerbat, stomatit, genito-urin.
   ac.ren.fail., urin.abnormalit.  to prev.NSAID use, aspir./NSAID sens., hist.of sev.allerg.react.incl.  disords incl.ac ren fail, hepatit with/ without jaund, vis disturbs, skin
   Warnings and special precautions: Hypertens., HF, may pre-  anaphylax./ angioed. induc.by aspirin /other NSAIDs, aspirin-induc.   reacts incl Stev.-Johns.& Lyell syndr, alopec, photosens react, imp
   cipit HF in comprom.pts., signific.CV event risk fact., high.GI bleed./  nasal polyps assoc.with bronchosp., childr. &lt; age of 1-2 yrs., heart   hear, tinnit, taste alterat, hypersens.reacts, vasculit, pneumonit.
   ulcerat./perforat. risk with incr.dos./pt.hist.thereof & elderly, discont.   fail., pregn. & lactat.  Special precautions: GI dis incl Crohn’s, hepat /ren fail, dyshae-
   if GI bleed./pept.ulc./hypersens.reacts./ hepat.dis sympt.occur, GI   Side effects: Freq: Abdom.discomf., pept. ulcerat, GI bleed., naus.,   mopoies, bld coag disords, poss masks S&S of infect, discont in pres
   dis.eg. ulcerat.colit./ Crohn’s dis./GORD, poss.masks S&S of infect.,   vomit., abdom. cramps/ pain. Less freq: Agranulocytos., thrombocy-  of gastr bleed, elderly, debilit & low body mass pts, may precipit. HF in
   imp. card./hepat./ren.funct., diuret.treatm., deplet. extra cellul.vol.,   topen., anaem., neutropen., eosinophil., tachycard., flush., incr. BP/  comprom pts, diuret treatm, deplet extra cellul vol, regul.bld monitor
   pre-exist.dyshaemopoies., bld. coag. disords., poss.incr.asept.men-  card.fail., dizzin., nervousn., depress., drowsin., insomn., headache,   advis dur longt use, discont if liv dis sympt devel.
   ingit.risk with SLE & mix.connect.tiss.disords., prem.foet.duct. arte-  tinnit., imp. ren. funct., ac.revers.ren.fail., oed., interstit.nephrit., ne-  Drug interactions: Toxic of methotrex.incr., bioavail. reduc by ace-
   riosus clos & persist.pulm.hypertens.in new born with reg.use in 3   rd  phrit. syndr., hepatit., blurr.vis., chang.vis.colour percept., toxic am-  tylsal acid & vice versa, poss rais Li & digox plasma conc, glucocortic
   trimmest., onset of labour delay. & durat.incr., determ.indiv.respons.  blyop., allerg.dermatit., erythema multiforme, bullous reacts.incl.   & other NSAIDs may aggrav. GI S/E, incr haemorrh risk with concom
   bef.driv. / operat.machin., 8-12 day interv.aft.mifepristone admin.,   Stev.-Johns.syndr./ toxic epiderm.necrolys., hypersens.reacts.incl.   anticoag therapy, poss adjustm to hypoglycaem agent dos, incr ne-
   distrib.in breast milk, fem.fertility poss.impair., blackcurr.cont.sacchar.  fev./ rash./hepatotox./asept.meningit., oed.  phrotoxic of cyclosporin, poss convuls with quinolones.
   Drug interactions: Incr.methotrex.toxic., more than one NSAID incr.   Warnings and special precautions: Infect. sympts. poss. mask.,
   adverse eff.risk, poss.rais.Li & digox.plasma conc., glucocortic. & other   elderly, pept.ulc./GI dis.hist., discont. if GI bleed./ulcerat.occ., discont.  LITHA NAPROXEN, Litha [P/S]
                                                              Naproxen sodium
   NSAIDs may aggrav.GI S/E, poss.adjustm.to antidiabet. dos.as either   at first appear. of skin rash/mucos.les./any sign of hypersens., premat.
   hypo-/hyperglycaem.poss., anticoag./ anti-platelet eff.poss.enhanc.,   clos.of foet.duct.aterios.in uterus & poss.persist.pulm.hypertens of   Indications: Mild to mod.sev.pain with inflammat. in condits.such
                                                              as musc.-skelet. trauma, pain follow.IUD insert., dysmenorrh., post
   bioavail.reduc.by acetylsal.acid & vice versa, GI bleed.risk.incr.by SS-  newborn if used reg.dur. 3  trimest.of pregn., onset of labour poss.   surg./-partum pain.
                                           rd
   RI’s, incr.nephrotoxic.of cyclosporin & tacrolimus, poss.convuls.with   delay., asthma, bronchosp., bleed. disord., CV dis., heart fail., cir-  (S3) TABS, 31/3.1/0274
   quinolones, antihypertens.eff.decr., incr.K+ ser.lev.with K+-spar.meds.,   rhos., diuret.-induc. vol. deplet., imp.ren./liv.funct., concom.coumar.   705300-001: 275 mg, 60, R315,30
   phenytoin expos.incr., mifepristone eff.reduc.  anticoags, discont. in pts.exper. blurr.or diminish.vis./chang.in col.  Dosage: Admin.with/aft.food.
   FORTFEN, (Aspen Pharmacare: Pharma) Pharmacare [P/S]  vis., pts.with collag.dis. poss.at incr.risk of develop.aseptic menin-  Ac.musc.skelet.disords: Init.2 tabs.follow.by 1 tab.3-4xdly.
                                git., anaem., stomatit., SLE, monit.pts.for develop.of bld./kidn./liv./
   Diclofenac sodium.           eye disords., hist.of hypertens.&/ heart fail. as fluid retent./oed.poss.  x7-14 days.
   Indications: Inflamm.& degenerat.forms of rheumat., rheumat.  Drug interactions: Eff.of oral anticoags.incr, alcohol/ corticoster./  Dysmenorrh: Init.2 tabs.follow.by 1 tab.3-4xdly as necess..
   arthrit., ankylos.spondylit., osteoarthros., spondylarthrit., pain-  clopidogrel./ticlopidine/ bisphosphon./ oxpentifylline/SSRIs incr.GI   Post-op pain: Init.2 tabs.follow.by 1 tab. 3-5xdly. as necess. with
                                                                        st
   ful musculo-skelet.condits., non-articul.rheumat., ac.gout attacks,   bleed. risk., eff.of antidiabet.agents poss.enhanc., plasma conc. of   max.dos.1 375 mg on 1  day.
   painful post-op/post-traumat.inflammat. & swell.follow.dent.surg.,   Li/methotrex./card.glycosid.incr., incr. nephrotoxic. risk with concom.  Post-part.pain: Sngl.dos.2 tabs.
   prim.dysmenorrh.             nephrotox.meds. incl. ciclospor., reduc./revers.antihypertens.eff.of   Contraindications: Pept.ulc., act.inflamm.dis., aspir./NSAID sen-
   (S3) SR CAPS, Y/3.1/189.     concom. antihypertens./diurets., leucopen.&/ thrombocytopen.eff.  sitiv./cross-sens., pregn. & lactat., not recomm.in childr.und.16 yrs.
   791547-078: 100 mg, 30, R123,61  of bone marr.depress.poss. incr., incr.S/E with two concom.NSAID’s  Side effects: GI disturbs.& bleed., CNS effs., vis. disturbs., tinnit.,
   Dosage: Admin.low.effect.dos.for shortest durat. of treatm. Take in   bld.dyscras., jaund., revers. ren. fail., interstit.nephrit., nephrot.syndr.,
   the even.when sympts.more pronounc.at night,/morn.  IBUGESIC FEVER & PAIN, Cipla Medpro [P/S]  haematur., hypersens.reacts., fluid retent., HF precipitat.in comprom.
   Adults: 1 cap.dly. Childr: und.14 yrs.not recomm.  Ibuprofen.  pts., incr.bleed.time due to decr. platel.aggregat.
   Contraindications: GI perforat./ulcerat./bleed. hist. relat.to prev.  Indications : Mild to mod.pain of inflammat. orig.with/without   Special precautions: NSAID cross-sens., pept. ulc. hist., elderly,
   NSAIDs, act./hist.of recur.GI ulc./perforat./ulcerat./haemorrh., other   fev., fev.of inflamm.origin, post-traumat.condits., emerg.ac.gout   asthma, bronchosp., bleed. disords., CV dis., liv./ren.fail., incr.asept.
   NSAID’s incl.aspir.hypersens., asthmat.pts.where ac. asthma attacks/  attacks x5 days.  menigit. risk with collag. dis., discont.if vis.changes occur, diuret. in-
   urticar./ac.rhinit.are precipitat.by acetylsalicyl. acid/med.with pros-  (S2) SUSP, 37/3.1/0467. 100 mg/5 ml  duc.vol.deplet,, concom.coumar. anticoags.
   taglandin synthetase inhibit.activ., porphyr., pregn.& lactat., childr.  704781-001: 100 ml, R41,72  Drug interactions: Observe for poss.potent. signs with hydan-
   und.14 yrs., heart/hepat.or ren.fail.  Dosage: Adults: Recomm.dos 600 mg 6-8 hrly. Tot.dly.dos.not to   toins/anticoags./ sulphonylureas & other highly prot.-bound meds.,
   Side effects: GI disturbs.incl.bleed., pept.ulc., on-specif.haemorrh.  exceed.1 200 mg.  probenecid incr.plasma lev.extend.half-life.
   colit., exacerbat.of ulcerat.colit./ Crohn’s proctocolit., glossit., aphth.  Childr: Tot.dly.dos 20 mg/kg bm.in div.dos.which is not to be exceed.  MEDIFLEX, (Ascendis) MDI [P/S]
   stomat., oesophag. les., diaphragm-like intest.strict., pancreatit.,   Pain: Init.dos: 5 mg/kg bm. Second dos.aft.2 hrs.if necess., there-  Indomethacin.
   alt.taste, bld.dyscras., hypersens. reacts. incl.anaphylax., disorien-  aft.4-6 hrly. Not exceed.20 mg/kg bm/ day.  Indications: Osteo & rheumat.arthrit., ankylos.spondylit., gout.,
   tat., anx., irritabil., depress., nightmares, psychot.reacts., headache,   Fev: 5 mg/kg bm 4-6 hrly.not exceed.20 mg/kg bm / day. 1-2 yrs (7-  ac.musc.skelet.disord.
   dizzin., nervousn, tiredn., sensat.disturbs., memory disturbs., insom.,   12 kg): 2,5 ml up to 3-4xdly. 3-7 yrs (14-23 kg): 2,5-5 ml up to 3-4xdly.   (S3) CAPS, X/3.1/167.
   convuls., trem., asept.meningit., somnol., cerebrovasc.accid., vis.  8-12 yrs (25-40 kg): 10 ml up to 3-4xdly.  788996-003; 25 mg 1 000, R160,22
   disturbs., vertigo, imp.hear., tinnit., palpitat., chest pain, hypertens.,   Childr.und.7 kg/und.1 yr : On doctors advice only.  Dosage: Use low.effect.dos.for short.poss.durat.
   CHF, oed., vasculit., asthma, dyspn., pneumonit., elev. transamin.lev.,   Contraindications: Heart fail., GI bleed./ perforat. relat.to prev.  25 mg 2-3xdly incr.if reqd.by 25-50 mg dly.at wkly interv.up to 150 mg
   hepat.with/without jaund., rash, urticar., skin reacts.incl.erythema   NSAID use, act./hist.of recurr. pept.ulc/heamorrh./perforat., aspir./  in div.dos.with food. Tot.dly dos.not to exceed 200 mg.
   multiform./ Stev.Johns.& Lyells.syndr., hair loss, photosens., purpura,   other NSAID hypersens., sev.allerg.react.hist., aspir. induc. nas.polyps.  Ac.gout: 50 mg 3xdly.
   ac.ren.fail., urin.abnormalit.  assoc.with bronchosp., childr. und.1 yr., pregn., lactat., bleed.tendenc.  Contraindications: HF, GI perforat./ulcerat./ bleed. relat. to prev.
   Special precautions: Hypertens., HF, elderly, high risk of GI ulcerat.&   disords., sev.ren./hepat.fail.  NSAIDs, act./hist of recurr. ulc./ haemorrh./perforat., gastrit., re-
   bleed.with incr.dos., withdr. if GI bleed./ulcerat.occurs, GI dis.hist., dis-  Side effects: Skin reacts.incl.exfoliat.dermatit./ Stev.John./& tox.  gion.enterit., ulcerat. colit., pregn., lactat., childr., psych. disords,
   cont. at 1  appear.of skin rash/mucos.les./ hypersens./vasculit./pneu-  epiderm.necrolys, rhinit., asept. meningit., bld.dyscras., hypersens.re-  epilep., Parkinson., ren.& hepat.dis., acetylsalicyl. hypersens., asth-
      st
   monit., may mask infects. sympts., high dos.methotrex.ther., monit.   acts., non-specific.allerg.reacts.& anaphylax., resp.tract reactiv., skin   mat.pts.sens.to aspirin.
   bld. gluc., 8-12 days interv.aft.mifepristone admin., fem. fertility poss.  disords., psych.& CNS disords., optic.neurit., blurr.vis., vis.col.percept.  Side effects: GI disturbs., pept.ulcerat., headache, sev. psychos.,
   impair., monit.imp.hepat.funct./ ren. fail & pre-exist.dyshaemopoiesis/  changes, tox.amblyop., vis.impairm., tox.optic neuropathy, tinnit., imp.  hallucinat., haematopoiet. reacts., CNS eff., hypersens. reacts.,
   bld.coagulat. disords., haemorrhage.disords., eye disords., incr. asept.   hear., vertigo, tachycard., card.fail., oed., flush., incr.BP, hypertens., GI   corneal opacit., vis.field chang., alopec., hyperglycaem., hyper-
   meningit.risk with SLE & mix.connect.tiss. disords., cont.sucrose.  disords.incl. pept.ulcerat.& GI bleed., Crohn’s dis.& colit. exacerbat.,   kalaem., vag.bleed., ren.fail., hepatit. & jaund., angioneurot.oed.,
   Drug interactions: Methotrex.toxic.incr., incr. Li/digox.plasma conc.,   pancreatit., hepatit., abnorm.liv.funct., hepat.fail., jaund., photos-  HF precipit., CV.disords.,
   corticoster./other syst. NSAIDs may exacerb.GI S/E., anticoags.effs.   ens., imp.ren.funct., ac. revers.ren.impairm., ren.fail., malaise, fatig.  Warnings and special precautions: Hist.of hypertens. &/ HF
   enhanc., Fortfen & acetylsalicyl.acid bioavail. reduc., SSRI’s/alcoh./  Special precautions: May mask infects., prem. clos.of foet.duc-  as fluid retent.& oed.poss., pts. with signif. risk facts.for CV events,
   biphosphon/oxypentifyll.incr. GI bleed. risk, nephrotoxic.of ciclospor.  tus arteriosus in utero with reg. NSAID use in 3  trimest., hypertens.,   elderly, pot. exacerbat. of GI dis.incl.Crohn’s dis./hiat.hern./ GORD/
                                                    rd
   incr., isol. convuls.report.with quinolones, antihypertens.eff. of diu-  HF, GI bleed. hist.& elderly have high.ulc.& GI bleed.risk, GI dis.hist.,   angiodysplas., discont.at first appear.of skin rash/ mucos.les./any
   ret.& antihypertens.agents decr., incr.ser.K  with K -spar.med., expos.  incr.GI S/E with two or more NSAID’s, low NSAID’s conc.appear in   other sign of hypersens., may mask S&S of infect.dis., reg.ophthal..
                    +
                       +
   to phenyt.incr., eff.of mifepristone reduc.  breast milk, elderly, imp.ren./hepat.funct., asthma, bronchosp., CV   exams. with prolong.use
   IBUCARE, (Unicorn) Austell [P/S]  dis., pept.ulc.hist., bleed.disords., CHF., diuret.induc. vol.deplet., dis-  Drug interactions: Probenecid incr plasma lev.& toxicit.risk, natriu-
                                cont.if vis.disturbs.exper., incr. risk of asept meningit.with collag.dis.
   Ibuprofen                    incl.SLE, S/E’s induc.by aspir./other NSAID’s, anaem., stomatit., con-  ret.& anti-hypertens.eff.of furosemide antagon., incr.S/E with con-
                                                              com. NSAID/ corticoster., eff.of anticoags.enhanc., incr. risk of GI
   (S2) When recomm.dly.dos.for adults does not exceed 1,2 g and   com.courmar.anticoags./oral corticoster./ antiplatel. agents/SSRI’s,
   for childr.upto & incl.12 yrs. 20 mg/kg bw, emerg.gout treatm., post   poss.impairm.of fem. fertility.  bleed.with concom.antiplatel.meds/ SSRIs.
   traumat. pain, swell & inflamm.for max.5 days.  Drug interactions:. Incr.GI bleed.risk with alcoh./corticoster./clopi-  MYLAN DICLOFENAC, Mylan [P/S]
   (S3) Inflamm.joint dis.treatm.  dogrel/ ticlopidine/ biphosphonates & pentoxifylline, anticoags.eff.   Diclofenac sodium.
   Indications: Rheumat.arthrit.incl.juven.arthrit., Still’s dis., osteoar-  enhanc., antidiab.agents effs.incr., digox.& Li ser.conc.incr., metho-  Indications: Rheumat.arthrit., osteoarthrit., ankylos.spondylit., post-
   thrit., ac.gouty arthrit., ankylos. spondylit., non-articul.rheumat., non-  trex.plasma lev.incr.& prolong., nephrotoxic.risk incr.with nephrotox.   traumat.pain & inflammat., prim.dysmenorrh.
   rheumat. inflammat.condits., soft.tiss.inj., mild to mod.pain, antipyret.  meds., antihypertens.effs.of antihypertens.agents & diuret.reduc./  (S3) TABS, [P/S] Y/3.1/148, 149
   (S2) & (S3) TABS, 42/3.1/0061, 0062  revers., leucopen/ thrombocytopen. eff. of bone marr.depress.incr.,   786012-013: 25 mg, 500, R80,20
   721114-001: 200 mg, 10, R18,16  incr.convuls.risk with quinolones, incr.haematologic.toxic.risk with zi-  786020-008: 50 mg, 21, R7,41
   721114-002: 200 mg, 20, R37,23  dovudine, aminoglycos.excret.decr., incr.bleed.risk with ginkgo biloba,   786020-016: 50 mg, 500, R176,43
   721116-001: 400 mg, 10, R26,84  CYP2C9 inhibit.incr.expos.  Dosage: Swallow whole with/aft.meals
   Dosage: Admin.with food. Low.effect.dos,for shortest durat.  Adults: 25-50 mg 3xdly depend.on sev. Maint: adjust.to minim.ef-
   Adults: Recomm.dos: 1 200 mg dly.in div.dos. Dos. may be incr.in sev.  K-FENAK, Cipla Medpro [P/S]  fect.dos. Childr: 2 mg/kg bm/day.
   condits.until ac.phase und.contr. Maint: 600-1200 mg/day in div.dos.  Diclofenac potassium  Contraindications: Act.GI bleed., pept.ulc., sev. hepat./ren.im-
   Dysmenorrh: 1 200 mg dly in 3 div.dos.  Indications: Emerg.treatm.for gout attacks & post-traumat.con-  pairm., aspir.-sens.pts., safety in pregn.not est.
   Dent./post-episiot.pain: Init: 800 mg.   dits.for max.5 days.  Side effects: GI disturbs.incl.ulcerat./haemorr., CNS eff., min.hear.
   Tot.dly. dos. no to exceed 2 400 mg. Revert to maint.dos. once   (S2) TABS, 38/3.1/0651  disords., oed., palpits., ocul. reacts., skin/hypersens.reacts., ren.funct.
   ac.phase und.contr.          704384-003: 50 mg, 9, R20,17  impairm., bld. dyscras.incl.haemolyt.anaem., ac.allerg. reacts. incl.
   Ac.gout: 2 400 mg dly giv.(as 800 mg 8 hrly OR 600 mg 6 hrly.) un-  Dosage: Short-term treatm  anaphylact.reacts., HF precipit.in compromis. pts.
   til.ac.phase reliev.         Adults: Init 100-150 mg/day in 2-3 div dos. Max dly dos 150 mg  Special precautions: Bld.counts advis.dur. prolong. treatm., CV dis.,
   Childr:                      Mild cases: 75-100 mg dly in div dos.  bleed.disords., coumar. anticoag. ther., imp.ren./hepat.funct., may
   Juv.rheum.arthrit: Tot.dly dos: 20 mg/kg bm in div. dos. Safety in   Contraindications: Hypersens to other NSAIDs. incl asprin, gastr/   mask S&S of infect., asthma, bronchoconstrict., elderly, bld. coag.
   childr.und.1 yr.not est.     duod ulc, asthmat pts where. acetylsalicyl. acid,/ other meds inhibit.  disords., concom.other prot-bound meds., poss. NSAID cross-sens.
   Pain: Init.dos: 5 mg/kg bm. Second dos.aft.2 hrs.if necess., there-  prostagland synthet, precip attack, pregn & lact., porphyr.  Drug interactions: Ser.interacts.with high dos. methotrex., decr.
   aft.4-6 hrly. Do not exceed. 20 mg/kg bm/day.   Side effects: Hypo-/hyperglycaem, bld dyscras, palpitat, chest pain,   plasma conc.with aspir., incr. Li/ digoxin plasma conc., glucocortic./
   Fev: 5 mg/kg bm 4-6 hrly. Do not exceed.20 mg/kg bm / day.  CHF,hypertens, oed, CNS eff, paraesthes, convuls, asept.meningit,   other NSAIDs may aggrav.GI S/E., poss.incr.probenecid half-life.</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page100.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page96.html">96</a>&nbsp;&nbsp;&nbsp;<a href="page97.html">97</a>&nbsp;&nbsp;&nbsp;<a href="page98.html">98</a>&nbsp;&nbsp;&nbsp;<a href="page99.html">99</a>&nbsp;&nbsp;&nbsp;<a href="page100.html">100</a>&nbsp;&nbsp;&nbsp;<a href="page101.html">101</a>&nbsp;&nbsp;&nbsp;<a href="page102.html">102</a>&nbsp;&nbsp;&nbsp;<a href="page103.html">103</a>&nbsp;&nbsp;&nbsp;<a href="page104.html">104</a>&nbsp;&nbsp;&nbsp;<a href="page105.html">105</a>&nbsp;&nbsp;&nbsp;<a href="page106.html">106</a>
             </td>
             <td width="35%"><a href="page102.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page102.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
